Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1
- PMID: 11145672
- DOI: 10.4049/jimmunol.166.2.952
Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1
Abstract
Th1 cells exposed to Ag and the G(1) blocker n-butyrate in primary cultures lose their ability to proliferate in Ag-stimulated secondary cultures. The ability of n-butyrate to induce anergy in Ag-stimulated, but not resting, Th1 cells was shown here to be blocked by cycloheximide. Subsequent experiments to delineate the nature of the protein apparently required for n-butyrate-induced Th1 cell anergy focused on the role of cyclin-dependent kinase (cdk) inhibitors p21(Cip1) and p27(Kip1). Normally, entry into S phase by Th1 cells occurs around 24 h after Ag stimulation and corresponds with relatively low levels of both p21(Cip1) and p27(Kip1). However, unlike control Th1 cells, anergic Th1 cells contained high levels of both p21(Cip1) and p27(Kip1) when examined 24 h after Ag stimulation. The increase in p21(Cip1) observed in Ag-stimulated anergic Th1 cells appeared to be initiated in primary cultures. In contrast, the increase in p27(Kip1) observed in these anergic Th1 cells appears to represent a re-expression of the protein much earlier than control cells following Ag stimulation in secondary cultures. The anergic Th1 cells contained functionally active cdk inhibitors capable of inhibiting the activity of both endogenous and exogenous cdks. Consequently, it appears that n-butyrate-induced anergy in Th1 cells correlated with the up-regulation of p21(Cip1) and perhaps the downstream failure to maintain low levels of p27(Kip1). Increased levels of both p21(Cip1) and p27(Kip1) at the end of G(1) could prevent cdk-mediated entry into S phase, and thus help maintain the proliferative unresponsiveness found in the anergic Th1 cells.
Similar articles
-
The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors.Immunology. 2002 Aug;106(4):486-95. doi: 10.1046/j.1365-2567.2002.01457.x. Immunology. 2002. PMID: 12153511 Free PMC article.
-
Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27(Kip1).Immunol Lett. 2002 Apr 22;81(2):149-55. doi: 10.1016/s0165-2478(01)00341-8. Immunol Lett. 2002. PMID: 11852120
-
The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.J Immunol. 2000 Oct 15;165(8):4346-52. doi: 10.4049/jimmunol.165.8.4346. J Immunol. 2000. PMID: 11035070
-
CDK inhibitors: positive and negative regulators of G1-phase progression.Genes Dev. 1999 Jun 15;13(12):1501-12. doi: 10.1101/gad.13.12.1501. Genes Dev. 1999. PMID: 10385618 Review. No abstract available.
-
Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.Curr Top Microbiol Immunol. 1998;227:105-20. doi: 10.1007/978-3-642-71941-7_5. Curr Top Microbiol Immunol. 1998. PMID: 9479827 Review. No abstract available.
Cited by
-
Identification of the genes specifically expressed in orally tolerized T cells.Cytotechnology. 2003 Nov;43(1-3):73-80. doi: 10.1023/b:cyto.0000039918.80472.0e. Cytotechnology. 2003. PMID: 19003210 Free PMC article.
-
Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21(waf1/cip1.).Cancer Immunol Immunother. 2013 Oct;62(10):1553-61. doi: 10.1007/s00262-013-1456-0. Epub 2013 Jul 4. Cancer Immunol Immunother. 2013. PMID: 23824498 Free PMC article.
-
Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation.BMC Immunol. 2005 Sep 21;6:22. doi: 10.1186/1471-2172-6-22. BMC Immunol. 2005. PMID: 16176581 Free PMC article.
-
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity.Vaccines (Basel). 2015 Sep 17;3(3):771-802. doi: 10.3390/vaccines3030771. Vaccines (Basel). 2015. PMID: 26393659 Free PMC article. Review.
-
Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy.Br J Ophthalmol. 2001 Aug;85(8):1001-6. doi: 10.1136/bjo.85.8.1001. Br J Ophthalmol. 2001. PMID: 11466262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous